Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,113 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT01274351

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Novartis Investigative Site Eskişehir, Meselik, Turkey (Türkiye)
  • Novartis Investigative Site Istanbul, TUR, Turkey (Türkiye)
  • Novartis Investigative Site Adana, Turkey (Türkiye)
  • Novartis Investigative Site Ankara, Turkey (Türkiye)
View all 13 locations
View Trial Details
Completed

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

NCT01696084

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Acute Myeloid Leukemia, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • University of CA San Diego San Diego, California, United States
  • Stanford University Stanford, California, United States
View all 43 locations
View Trial Details
Completed

Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

NCT01830361

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Klinikum Chemnitz gGmbH, Klinik für Innere Medizin III Chemnitz, Germany
  • Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I Dresden, Germany
  • Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany
  • Klinikum der Johann-Wolfgang-Goethe Universität Frankfurt am Main, Germany
View Trial Details
Completed

Beat AML Core Study

NCT02927106

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • UF Health Cancer Center Gainesville, Florida, United States
View Trial Details
Completed

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

NCT00946647

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States
  • Goshen Center for Cancer Care IU Cancer Center Indianapolis, Indiana, United States
  • University of Kansas Hospital and Medical Center SC - Univ KS Kansas City, Kansas, United States
  • Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
View all 38 locations
View Trial Details

Related conditions